J N Anasti1, S N Kalantaridou, L M Kimzey, R A Defensor, L M Nelson. 1. Section on Women's Health, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, and the Clinical Center Nursing Department, National Institutes of Health, Bethesda, Maryland 20892-1862, USA.
Abstract
OBJECTIVE: To evaluate the effects of karotypically normal spontaneous premature ovarian failure on femoral neck bone mineral density. METHODS: Eighty-nine women with karyotypically normal spontaneous premature ovarian failure who desired fertility were evaluated at a tertiary care academic center and underwent hip and spinal bone density measurements by conventional dual-photon absorptiometry. Seventy-seven of the women (87%) had sought medical advice previously and had taken a variety of estrogen and progestin replacement regimens at least intermittently. The median (range) age was 32 (20-39) years, and the median (range) time since diagnosis was 1.5 (0.5-11) years. Findings were compared with a reference group of 218 regularly menstruating women of similar age. RESULTS: Sixty of the 89 women with premature ovarian failure (67%, 95% confidence interval 57, 77) had a femoral neck bone mineral density more than 1 standard deviation (SD) below the mean of the reference group (P < .001, chi2 with Yates correction). Even in women in whom the bone mineral density measurement was made within just 1.5 years of the diagnosis, nearly one-half (47%) had a femoral neck bone mineral density more than 1 SD below the mean of the reference group (P < .01). CONCLUSION: Two-thirds of young women with karyotypically normal spontaneous premature ovarian failure have a femoral neck bone mineral density more than 1 SD below the mean of a reference group. These young women need early education regarding strategies to maintain their bone mass and ongoing medical evaluation to maintain compliance with these strategies.
OBJECTIVE: To evaluate the effects of karotypically normal spontaneous premature ovarian failure on femoral neck bone mineral density. METHODS: Eighty-nine women with karyotypically normal spontaneous premature ovarian failure who desired fertility were evaluated at a tertiary care academic center and underwent hip and spinal bone density measurements by conventional dual-photon absorptiometry. Seventy-seven of the women (87%) had sought medical advice previously and had taken a variety of estrogen and progestin replacement regimens at least intermittently. The median (range) age was 32 (20-39) years, and the median (range) time since diagnosis was 1.5 (0.5-11) years. Findings were compared with a reference group of 218 regularly menstruating women of similar age. RESULTS: Sixty of the 89 women with premature ovarian failure (67%, 95% confidence interval 57, 77) had a femoral neck bone mineral density more than 1 standard deviation (SD) below the mean of the reference group (P < .001, chi2 with Yates correction). Even in women in whom the bone mineral density measurement was made within just 1.5 years of the diagnosis, nearly one-half (47%) had a femoral neck bone mineral density more than 1 SD below the mean of the reference group (P < .01). CONCLUSION: Two-thirds of young women with karyotypically normal spontaneous premature ovarian failure have a femoral neck bone mineral density more than 1 SD below the mean of a reference group. These young women need early education regarding strategies to maintain their bone mass and ongoing medical evaluation to maintain compliance with these strategies.
Authors: B Frey Tirri; P Häusermann; H Bertz; H Greinix; A Lawitschka; C-P Schwarze; D Wolff; J P Halter; D Dörfler; R Moffat Journal: Bone Marrow Transplant Date: 2014-10-27 Impact factor: 5.483
Authors: Vaishali B Popat; Karim A Calis; Sophia N Kalantaridou; Vien H Vanderhoof; Deloris Koziol; James F Troendle; James C Reynolds; Lawrence M Nelson Journal: J Clin Endocrinol Metab Date: 2014-06-06 Impact factor: 5.958
Authors: Patricia P Jumbo-Lucioni; Kathryn Garber; John Kiel; Ivo Baric; Gerard T Berry; Annet Bosch; Alberto Burlina; Ana Chiesa; Maria Luz Couce Pico; Sylvia C Estrada; Howard Henderson; Nancy Leslie; Nicola Longo; Andrew A M Morris; Carlett Ramirez-Farias; Susanne Schweitzer-Krantz; Susanne Scheweitzer-Krantz; Catherine Lynn T Silao; Marcela Vela-Amieva; Susan Waisbren; Judith L Fridovich-Keil Journal: J Inherit Metab Dis Date: 2012-03-27 Impact factor: 4.982
Authors: Shannon D Sullivan; Amy Lehman; Fridtjof Thomas; Karen C Johnson; Rebecca Jackson; Jean Wactawski-Wende; Marcia Ko; Zhao Chen; J David Curb; Barbara V Howard Journal: Menopause Date: 2015-10 Impact factor: 2.953
Authors: Shane Lipskind; Jennifer S Lindsey; Behzad Gerami-Naini; Jennifer L Eaton; Daniel O'Connell; Adam Kiezun; Joshua W K Ho; Nicholas Ng; Parveen Parasar; Michelle Ng; Michael Nickerson; Utkan Demirci; Richard Maas; Raymond M Anchan Journal: Reprod Sci Date: 2017-08-31 Impact factor: 3.060